1 Nov 2017 16:29
1 November 2017
Immunodiagnostic Systems Holdings plc (the "Company")
Additional Listing
Application has today been made to AIM for admission of 35,000 new Ordinary Shares of 2 pence each in the Company ("Shares"). These Shares, which will rank pari passu in all respects with the existing shares in issue, are being issued pursuant to the exercise of options under the Company's Unapproved Share Option Scheme.
Admission is expected to become effective on 7 November 2017. Following admission to trading of the Shares, the Company will have 29,450,175 Ordinary Shares of 2 pence each in issue of which 12,447 are held as treasury shares leaving a balance of 29,437,728 ordinary shares with voting rights.
For further information:
Immunodiagnostic Systems Holdings plc | Tel: +44 (0) 191 519 0660 |
Paul Martin, Group Finance Director | |
Peel Hunt LLP | Tel: +44 (0) 20 7418 8900 |
James Steel | |
Oliver Jackson |